Cytarabine and daunorubicin liposomal
Generic name: Cytarabine And Daunorubicin (liposomal)
Brand names: Vyxeos
Dosage form: intravenous powder for injection (100 mg-44 mg)
Drug class:
Antineoplastic combinations
Usage of Cytarabine and daunorubicin liposomal
Cytarabine and daunorubicin liposomal is a combination medicine used to treat acute myeloid leukemia that is newly diagnosed in adults and children at least 1 year old.
Cytarabine and daunorubicin liposomal may also be used for purposes not listed in this medication guide.
Cytarabine and daunorubicin liposomal side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Cytarabine and daunorubicin liposomal can make it easier for you to bleed. Call your doctor or seek emergency medical attention if you have:
Cytarabine and daunorubicin may cause serious side effects. Call your doctor at once if you have:
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of cytarabine and daunorubicin may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Cytarabine and daunorubicin liposomal
You should not be treated with this medicine if you are allergic to cytarabine or daunorubicin.
Tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
Both men and women using this medicine should use effective birth control to prevent pregnancy. Cytarabine and daunorubicin liposomal can harm an unborn baby if the mother or father is using this medicine.
Keep using birth control for at least 6 months after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using this medicine.
It may be harder for you to get a woman pregnant while you are using this medicine. You should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.
You should not breastfeed while using this medicine and for at least 2 weeks after your last dose.
Relate drugs
- Akeega
- Cytarabine and daunorubicin liposomal
- Cedazuridine and decitabine
- Daunorubicin and cytarabine liposome
- Decitabine and cedazuridine
- Inqovi
- Kisqali Femara Co-Pack
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Letrozole and ribociclib
- Lonsurf
- Niraparib and abiraterone
- Nivolumab and relatlimab
- Nivolumab/relatlimab-rmbw
- Opdualag
- Ribociclib and letrozole
- Tipiracil and trifluridine
- Trifluridine and tipiracil
- Vyxeos
- Vyxeos liposomal
How to use Cytarabine and daunorubicin liposomal
The liposomal combination of cytarabine and daunorubicin is not given in the same doses or on the same schedule as other forms of cytarabine or daunorubicin. If you have used either of these medicines before, your dose schedule of cytarabine and daunorubicin liposomal may be different.
Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using cytarabine and daunorubicin.
Cytarabine and daunorubicin liposomal is given as an infusion into a vein. A healthcare provider will give you this injection.
This medicine must be given slowly, and the infusion can take at least 90 minutes to complete.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
Cytarabine and daunorubicin liposomal is usually given every other day for up to 3 infusions in a 5-day treatment cycle. If you need additional treatment cycles, you will need to wait 5 to 8 weeks before you receive the medicine again.
You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.
Cytarabine and daunorubicin liposomal doses are based on body surface area (height and weight). Your dose needs may change if you gain or lose weight or if you are still growing.
Your doctor will determine how long to treat you with this medicine.
This medicine can make it easier for you to bleed. Contact your doctor or seek emergency medical attention if you have easy bruising, unusual bleeding, or any bleeding that will not stop.
Warnings
cytarabine and daunorubicin can make it easier for you to bleed. Contact your doctor or seek emergency medical attention if you have easy bruising, unusual bleeding, or any bleeding that will not stop. You may also have bleeding on the inside of your body, such as in your stomach or intestines, or in your brain.
Call your doctor at once if you have: signs of bleeding in your digestive tract--feeling very weak or dizzy, severe stomach pain, black or bloody stools, or if you cough up blood or vomit that looks like coffee grounds; or signs of bleeding in the brain--sudden numbness or weakness (especially on one side of the body), sudden severe headache, or problems with vision or balance.
What other drugs will affect Cytarabine and daunorubicin liposomal
Other drugs may affect cytarabine and daunorubicin liposomal, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions